Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
Johnson and Johnson
Mallinckrodt
Dow
AstraZeneca
Boehringer Ingelheim

Last Updated: December 12, 2019

DrugPatentWatch Database Preview

PROPOXYPHENE HYDROCHLORIDE Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

When do Propoxyphene Hydrochloride patents expire, and when can generic versions of Propoxyphene Hydrochloride launch?

Propoxyphene Hydrochloride is a drug marketed by Alra, Impax Labs, Ivax Sub Teva Pharms, Mutual Pharm, Mylan, Nexgen Pharma Inc, Par Pharm, Purepac Pharm, Pvt Form, Roxane, Sandoz, Teva, Valeant Pharm Intl, Vintage Pharms, Watson Labs, West Ward, Whiteworth Town Plsn, and Warner Chilcott. and is included in thirty-two NDAs.

The generic ingredient in PROPOXYPHENE HYDROCHLORIDE is aspirin; caffeine; propoxyphene hydrochloride. There are twenty-two drug master file entries for this compound. Additional details are available on the aspirin; caffeine; propoxyphene hydrochloride profile page.

Summary for PROPOXYPHENE HYDROCHLORIDE
Drug patent expirations by year for PROPOXYPHENE HYDROCHLORIDE
Recent Clinical Trials for PROPOXYPHENE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Mansoura UniversityPhase 1/Phase 2
Federal University of São PauloPhase 4
Fundação de Amparo à Pesquisa do Estado de São PauloPhase 4

See all PROPOXYPHENE HYDROCHLORIDE clinical trials

Synonyms for PROPOXYPHENE HYDROCHLORIDE
(+)-1,2-Diphenyl-2-propionoxy-3-methyl-4-dimethylaminobutane hydrochloride
(+)-Propoxyphene hydrochloride
(|AS)-|A-[(1R)-2-(Dimethylamino)-1-methylethyl]-|A-phenylbenzeneethanol Propanoate Hydrochloride
(2S,3R)-(+)-4-(Dimethylamino)-3-methyl-1,2-diphenyl-2-butanol propionate (ester) hydrochloride
(2S,3R)-(+)-4-(Dimethylamino)-3-methyl-1,2-diphenyl-2-butanol propionate hydrochloride
[(1S,2R)-1-benzyl-3-(dimethylamino)-2-methyl-1-phenyl-propyl] propanoate hydrochloride
[(2S,3R)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] propanoate hydrochloride
[(2S,3R)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] propanoate;hydrochloride
[4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] propanoate hydrochloride
1639-60-7
2-Butanol, 4-(dimethylamino)-3-methyl-1,2-diphenyl-, propionate (ester), hydrochloride, (+)-
2-Butanol, 4-(dimethylamino)-3-methyl-1,2-diphenyl-, propionate (ester), hydrochloride, (L)-
25312-78-1
56533-07-4
62-69-1
6414-50-2
642 Tablets
6585-54-2
Abalgin
AC1L25NW
AC1L25VI
Algaphan
alpha-d-Propoxyphene hydrochloride
AN-20665
Anatalvic
API0002285
Benzeneethanol, .alpha.-[(1R)-2-(dimethylamino)-1-methylethyl]-.alpha.-phenyl-, 1-propanoate, hydrochloride (1:1), (.alpha.S)-
Benzeneethanol, alpha-((1R)-2-(dimethylamino)-1-methylethyl)-alpha-phenyl-, 1-propanoate, hydrochloride (1:1), (alphaS)-
Benzeneethanol, alpha-((1R)-2-(dimethylamino)-1-methylethyl)-alpha-phenyl-, propanoate (ester), hydrochloride, (alphaS)-
Benzeneethanol, alpha-(2-(dimethylamino)-1-methylethyl)-alpha-phenyl-, propanoate (ester), hydrochloride, (S-(R*,S*))-
Benzeneethanol, alpha-(2-(dimethylamino)-1-methylethyl)-alpha-phenyl-, propanoate (ester), hydrochloride, (S-(theta,S))-
CAS-1639-60-7
CB2TL9PS0T
CHEBI:8498
CHEMBL1237104
d-4-Dimethylamino-3-methyl-1,2-diphenyl-2-butanol propionate hydrochloride
d-Propoxyphene monohydrochloride
D00482
Darvon
Darvon (TN)
Darvon with A.S.A
Darvon with A.S.A.
DEA No. 9278
Deprancol
Depronal
Depronal retard
Develin
Dextro Propoxyphene HCl
Dextropropofixen Dak
DEXTROPROPOXIPHENE CHLORIDE
Dextropropoxyphene hydrochloride
Dolene
Dolotard
Doloxene
Doraphen
DSSTox_CID_28839
DSSTox_GSID_48913
DSSTox_RID_83108
DTXSID6048913
EINECS 216-484-3
EINECS 216-683-5
Erantin
FT-0674086
Kesso-Gesic
L-Propoxyphene hydrochloride
Levopropoxyphene hydrochloride
Liberen
LS-46519
LS-46520
Mardon
Margesic Improved
NCGC00247706-01
Novopropoxyn
Paljin
Prophene
Prophene 65
Propoxyphene HCl
Propoxyphene hydrochloride (USP)
Propoxyphene hydrochloride [USAN:USP]
Propoxyphene hydrochloride [USAN]
Propoxyphene hydrochloride 65
Propoxyphene Hydrochloride Salt
Propoxyphene-d7 hydrochloride salt(mixture of diastereoisomers)
QMQBBUPJKANITL-MYXGOWFTSA-N
Romidon
s-alpha-(2-(Dimethylamino)-1-methylethyl)-alpha-phenylbenzeneethanol propioate hydrochloride
SCHEMBL41779
SCHEMBL9269
SK-65 Apap
Tox21_112860
UNII-CB2TL9PS0T
W-109688
Zideron

US Patents and Regulatory Information for PROPOXYPHENE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs PROPOXYPHENE HYDROCHLORIDE AND ACETAMINOPHEN acetaminophen; propoxyphene hydrochloride TABLET;ORAL 040139-001 Dec 16, 1996 DISCN No No   Start Trial   Start Trial   Start Trial
Mylan PROPOXYPHENE HYDROCHLORIDE AND ACETAMINOPHEN acetaminophen; propoxyphene hydrochloride TABLET;ORAL 083689-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs PROPOXYPHENE HYDROCHLORIDE W/ ASPIRIN AND CAFFEINE aspirin; caffeine; propoxyphene hydrochloride CAPSULE;ORAL 085732-002 Sep 3, 1984 DISCN No No   Start Trial   Start Trial   Start Trial
Mylan PROPOXYPHENE HYDROCHLORIDE AND ACETAMINOPHEN acetaminophen; propoxyphene hydrochloride TABLET;ORAL 083978-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Alra PROPOXYPHENE HYDROCHLORIDE propoxyphene hydrochloride CAPSULE;ORAL 083184-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Sandoz PROPOXYPHENE HYDROCHLORIDE propoxyphene hydrochloride CAPSULE;ORAL 083870-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Express Scripts
McKinsey
AstraZeneca
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.